Fundraising Fox

Tal Zaks

Investor

Partner at OrbiMed · Board director at Averna Therapeutics

Newton, Massachusetts, United States

Find your path to Tal

629 people in our graph share verified history with Tal — schools, employers, funds. One of them is your warm intro.

Assaf ArakiunlockedTal: together at Ben-Gurion University of the Negev (1998–2000)
×3Tal: together at University of Pennsylvania
×2Tal: together at Adaptimmune
Tal: together at Moderna

About

Partner at OrbiMed holding both M.D. and Ph.D. degrees.

Board director at Averna Therapeutics

Intro paths

→

In turn, Tal can intro founders to Averna Therapeutics's investors below.

Averna Therapeutics's investors · 4

Deep InsightTel AvivDelos CapitalCambridgeNovartis Venture FundBasel · $5M – $25M checksOrbiMedNew York · $1M – $75M checks · since 2024

Experience

  1. OrbiMedPartner, Private Equitycurrent2022 — presentBoston, Massachusetts, United States
  2. OrbiMedVenture Partner2021 — 2022
  3. Averna TherapeuticsExecutive Chairmancurrent2024 — presentBoston, Massachusetts, United States
  4. Curevo VaccineNon Executive Directorcurrent2025 — present
  5. Minervax ApSNon Executive Directorcurrent2023 — presentDenmark
  6. Convergent Therapeutics, Inc.Non Executive Directorcurrent2023 — presentMassachusetts, United States
  7. iECURE, inc.Non Executive Directorcurrent2022 — presentPhiladelphia, Pennsylvania, United States
  8. Teva PharmaceuticalsNon Executive Directorcurrent2021 — present
  9. University of PennsylvaniaAdjunct Associate Professor of Medicine, School of Medicinecurrent2004 — present
  10. PIC TherapeuticsNon Executive Director2022 — 2025Massachusetts, United States
  11. Adaptimmune USNon Executive Director2016 — 2023
  12. Moderna TherapeuticsChief Medical Officer2015 — 2021Cambridge, MA
  13. SanofiSVP, Head of Sanofi Oncology2013 — 2015Cambridge, MA
  14. SanofiVP, Head of Development, Oncology Division2010 — 2014Cambridge, MA
  15. VA Medical CenterAttending, Medical Oncology2008 — 2010
  16. CephalonVP, Clinical Research Oncology2008 — 2010
  17. GlaxoSmithKlineDirector, clinical development and translational medicine2004 — 2008
  18. University of Pennsylvania School of MedicineClinical Fellow2002 — 2004
  19. Temple University HospitalResident1999 — 2002
  20. National Cancer InstitutePostdoctoral fellow1996 — 1999

Deals · 1

Curevo, Inc.Board seat

via OrbiMed · filed Mar 2025 · $84.8M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at OrbiMed

Aldo Brambilla
Associate at Silver Lake Partners
Alexander M. Cooper
Investor at OrbiMed
Anat Naschitz
Executive Officer at OrbiMed
Anat Nursella
Venture Partner at OrbiMed
Andrew P. Kanarek, CFA, CIPM
Investor at OrbiMed
Ankesh Bhansali
Investor at OrbiMed
Arun Sadhanandham
Investor at OrbiMed
Ava Poole
Investor at Insight Partners

Frequently asked questions

Who is Tal Zaks?
Partner at OrbiMed holding both M.D. and Ph.D. degrees.
Where does Tal Zaks work?
Tal Zaks is Partner at OrbiMed and Board director at Averna Therapeutics.
What boards does Tal Zaks sit on?
Tal Zaks holds tracked board seats at Curevo, Inc..
Where did Tal Zaks go to school?
Tal Zaks studied at University of Pennsylvania School of Medicine (Clinical Fellow, Hematology-Oncology); Ben-Gurion University of the Negev (PhD, Tumor Immunology); Ben-Gurion University of the Negev (MD).

Same school

Also attended University of Pennsylvania School of Medicine47

René KuijtenInvestor at LSP (Life Sciences Partners)Jun JeonInvestor at Khosla VenturesEric ShanAssociate at 7wire VenturesSeth GlickmanDigital Health Advisor at Excelerate Health VenturesJonathan LeffExecutive Partner, Private Equity at Sofinnova VenturesAaron NelsonPartner at Novo Holdings

+ 41 more

Also attended Ben-Gurion University of the Negev157

Assaf ArakiInvestment Director at Intel CapitalJonathan PacificiVenture Capitalist, Entrepreneur and Community Leader; General Partner at Sixth Millennium Venture Partners at Sixth Millennium Venture Partners Management, LlcYair SchindelCo-Founder & Managing Partner at aMoonShimon TsentsiperVenture Partner at Key1 CapitalRoy KimchiSenior Associate at Square Peg CapitalAtad PeledPartner at Red Dot Capital Partners

+ 151 more

Also attended Bar-Ilan University149

Yaron CarniFounder at Maverick Ventures IsraelRochelle RamVP Finance at Maverick Ventures IsraelGil RotenbergInvestment Principal at Samsung Catalyst FundDina RaabController at PeakSpan Capital PartnersAdi HarariCFO at Key1 CapitalBarak SalomonManaging Partner at Red Dot Capital Partners

+ 143 more

Shared employers

Also worked at Averna Therapeutics5

Mathias FrederiksenPrincipal at Novartis Venture FundJason GabrielManaging Director at Syngenta Group VenturesNick OlsenPrincipal at Innovation EndeavorsEric HuangPartner at Delos CapitalDylan MorrisManaging Director at Insight Partners

Also worked at Curevo Vaccine2

Kabeer AzizCo-Founder and Partner at Adjuvant CapitalMario BarroVenture Partner at RA Capital

Also worked at University of Pennsylvania187

Wesley BarrowPartner at Correlation VenturesDavid MagermanManaging Partner at Differential VenturesNuan ZhangInvestor at Episode1Vyas RamananVenture Partner at Third Rock VenturesLouis BernemanFounding Partner at Osage University PartnersBrian HalakManaging Partner at Medical Excellence Capital

+ 181 more

Also worked at Moderna Therapeutics21

Dave JohnsonCo-founder & CEO of Dash BioNoubar AfeyanInvestor at Flagship PioneeringGisella de la RochaVice President of Legal at MPM BioImpactJordan SilvaCampus Lead at The MBA FundLee CooperManaging Director at Delos CapitalEric HuangPartner at Delos Capital

+ 15 more